Sprinklr Announces Third Quarter Fiscal 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Cardium Therapeutics, Inc. (NYSE: CXM) | Delayed: 6.59 +0.17 (2.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.42 | 52 Week High | $1.44 | |||
| Open | $6.48 | 52 Week Low | $0.06 | |||
| Day High | $6.60 | P/E | N/A | |||
| Day Low | $6.46 | EPS | $-1.24 | |||
| Volume | 353,848 | |||||
